FHCCX
Price
$38.26
Change
-$0.54 (-1.39%)
Updated
Sep 25 closing price
Net Assets
N/A
JFNIX
Price
$68.93
Change
-$1.25 (-1.78%)
Updated
Sep 25 closing price
Net Assets
4.49B
Interact to see
Advertisement

FHCCX vs JFNIX

Header iconFHCCX vs JFNIX Comparison
Open Charts FHCCX vs JFNIXBanner chart's image
Fidelity Advisor Health Care C
Price$38.26
Change-$0.54 (-1.39%)
VolumeN/A
Net AssetsN/A
Janus Henderson Global Life Sciences I
Price$68.93
Change-$1.25 (-1.78%)
VolumeN/A
Net Assets4.49B
FHCCX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FHCCX vs. JFNIX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHCCX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX pays higher dividends than FHCCX: JFNIX (0.39) vs FHCCX (0.00). FHCCX was incepted earlier than JFNIX: FHCCX (28 years) vs JFNIX (16 years). FHCCX (1.69) is less costly to investors than JFNIX (0.77). FHCCX is a more actively managed with annual turnover of: 37.00 vs. JFNIX (35.00). FHCCX has a lower initial minimum investment than JFNIX: FHCCX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -12.39 vs. FHCCX (-21.46). JFNIX return over 5 years is better than : 8.34 vs. FHCCX (-18.06).
FHCCXJFNIXFHCCX / JFNIX
Total Expense Ratio1.690.77219%
Annual Report Gross Expense Ratio1.690.77219%
Fund Existence28 years16 years-
Gain YTD-0.4623.176-15%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A4.49B-
Annual Yield % from dividends0.000.39-
Returns for 1 year-21.46-12.39173%
Returns for 3 years-3.2221.30-15%
Returns for 5 years-18.068.34-216%
Returns for 10 years38.2839.2897%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUEX12.57N/A
N/A
Lazard US Equity Concentrated R6
FBDIX143.61N/A
N/A
Franklin Biotechnology Discovery A
CFSIX21.84N/A
N/A
Touchstone Sands Capital Select Growth Y
TIBRX31.71N/A
N/A
Thornburg Investment Income Builder R3
BIRDX8.53N/A
N/A
iShares Developed Real Estate Idx Instl